Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Transcriptome Analysis at Locus-Specific Resolution Identified Alteration in Human Endogenous Retroviruses, a Class of Transposable Elements in Mantle Cell Lymphoma

Alessandro La Ferlita, Nicholas Staudinger, Lara Bayraktar, Katherine Chiappinelli, Lapo Alinari, Robert Baiocchi, Lalit Sehgal, Mamta Gupta

Blood (2024) 144 (Supplement 1): 1611.

https://doi.org/10.1182/blood-2024-208604

Published: 2024

Journal Articles

Macrophages in Waldenstrom Macroglobulinemia: Implications for the Tumor Microenvironment

Ava J Boutilier, Mohammad Raad, Sherine Elsawa, Kailey E Paar, Stephan J Matissek, Cameron E Banks, Allison Carl, Anna D Metzler, Jenna M Murray, Mamta Gupta, Katja U Koeppen, Michael J. Rauh

Blood (2024) 144 (Supplement 1): 4386.

https://doi.org/10.1182/blood-2024-199134

Published: 2024

Journal Articles

Transcriptomic Analysis in Mantle Cell Lymphoma Patients Identified MALAT1 Long-Non-Coding RNA to Regulate Cell Cycle Progression By Modulating EZH2/p57/Sox11 Axis

Satishkumar Singh, Alessandro La Ferlita, Neeraj Jain, Maxine Berger, Sriya Sreekanth, Rosario Distefano, Mamta Gupta, Natarajan Muthusamy, Robert Baiocchi, Lapo Alinari, Narendranath Epperla, Lalit Sehgal

Blood (2024) 144 (Supplement 1): 4350.

https://doi.org/10.1182/blood-2024-209941

Published: 2024

Journal Articles

Tumor Microenvironment-Induced Interleukin-6 Regulates Proliferation and Survival in Patients with Mantle Cell Lymphoma (MCL) By Activating FGFR1 Signaling

Yuangfeng Wang, Satishkumar Singh, Audrey Odier, Alessandro La Ferlita, Wing Chan, Maxine Berger, Sriya Sreekanth, Narendranath Epperla, Natarajan Muthusamy, Robert Baiocchi, Lapo Alinari, Mamta Gupta, Lalit Sehgal

Blood (2024) 144 (Supplement 1): 4371.

https://doi.org/10.1182/blood-2024-209186

Published: 2024

Journal Articles

Oncogenic Role of Chromatin Modifier Polycomb Repressive Complex-2 in Mantle Cell Lymphoma

Mamta Gupta, PhD, Christos Demosthenous, MD, Mary J Stenson, Tammy Price-Troska, BS

Blood (2018) 132 (Supplement 1): 1582.

https://doi.org/10.1182/blood-2018-99-118957

Published: 2018

Journal Articles

Targeting Bromodomain and External Domain Epigenetic Reader Protein As Effective Strategy for Double-Hit and Triple-Hit B-Cell Lymphoma

Weiping Li, MD, Shiv K Gupta, PhD, Ryan Knudson, MS, Weighu Han, BS, Sherine Elsawa, PhD, Patricia Griepp, MD, Mamta Gupta, PhD

Blood (2017) 130 (Supplement 1): 1472.

https://doi.org/10.1182/blood.V130.Suppl_1.1472.1472

Published: 2017

Journal Articles

Selective Inhibition of HDAC1 and HDAC3 Inhibits Survival of Diffuse Large Cell Lymphoma Via Epigenetic Modulation of Death Associated Protein (DAPK)

Dominique Pandy, BS, Emily Mesev, MS, Mamta Gupta, PhD

Blood (2017) 130 (Supplement 1): 4020.

https://doi.org/10.1182/blood.V130.Suppl_1.4020.4020

Published: 2017

Journal Articles

The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma

Thomas E. Witzig, Craig Reeder, Jing Jing Han, Betsy LaPlant, Mary Stenson, Han W. Tun, William Macon, Stephen M. Ansell, Thomas M. Habermann, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Joseph P. Colgan, Svetomir Markovic, Grzegorz S. Nowakowski, Mamta Gupta

Blood (2015) 126 (3): 328–335.

https://doi.org/10.1182/blood-2015-02-629543

Published: 2015

Includes: Supplemental data

Journal Articles

Loss-of-Function Missense Mutations in Tyrosine Phosphatase PTPN6 Deregulate STAT3 Signaling in Diffuse Large B-Cell Lymphoma

Christos Demosthenous, Guangzhen Hu, PhD, Thomas E Witzig, MD, Mamta Gupta, PhD

Blood (2014) 124 (21): 707.

https://doi.org/10.1182/blood.V124.21.707.707

Published: 2014

Journal Articles

Mantle Cell Lymphoma Associated Long Non-Coding RNAs Regulate Polycomb Repressive Complex-2

Guangzhen Hu, PhD, Asha Nair, M.S, Tammy Price-Troska, B.S, Eric D Wieben, PhD, Mamta Gupta, PhD

Blood (2014) 124 (21): 140.

https://doi.org/10.1182/blood.V124.21.140.140

Published: 2014

Journal Articles

Elevated Soluble IL-2Ra Levels Are Associated With Inferior Outcome and Is Independent Of MIPI Score in Patients With Mantle Cell Lymphoma

Mohamad Bassam, M.D, Matthew J Maurer, MS, Mary Stenson, B.S, Linda E Wellik, Christine Allmer, Brian K Link, MD, James R Cerhan, MD, PhD, Thomas E Witzig, MD, Mamta Gupta, Ph.D

Blood (2013) 122 (21): 4256.

https://doi.org/10.1182/blood.V122.21.4256.4256

Published: 2013

Journal Articles

Repression Of Cap-Dependent Translation With a Next-Generation mTOR Inhibitor Attenuates c-Myc Transcription and Survival In Lymphoma Cells

Mamta Gupta, Ph.D, Jing Jing Han, Mary Stenson, B.S, Linda E Wellik, Thomas E Witzig, MD

Blood (2013) 122 (21): 636.

https://doi.org/10.1182/blood.V122.21.636.636

Published: 2013

Journal Articles

In-Vivo Activation Of STAT3 In Angioimmunoblastic T Cell Lymphoma, PTCL Not Otherwise Specified, and ALK Negative Anaplastic Large Cell Lymphoma: Implications For Therapy

Mamta Gupta, Ph.D, Matthew J. Maurer, MS, Mary Stenson, B.S, Linda E. Wellik, Jing Jing Han, Andrew L. Feldman, Thomas M. Habermann, MD, Thomas E. Witzig, MD

Blood (2013) 122 (21): 844.

https://doi.org/10.1182/blood.V122.21.844.844

Published: 2013

Journal Articles

A Novel Long Non-Coding RNA, SNHG4 Complex With Eukaryotic Initiation Factor-4E and Regulate Aberrant Protein Translation In Mantle Cell Lymphoma: Implications For Novel Biomarker

Guangzhen Hu, Thomas E Witzig, MD, Mamta Gupta, Ph.D

Blood (2013) 122 (21): 81.

https://doi.org/10.1182/blood.V122.21.81.81

Published: 2013

Journal Articles

SHP1 Suppression In Diffuse Large B Cell Lymphoma Is Regulated Through Promoter Hypermethylation At Novel CpG2 Island and H3K27 Trimethylation Histone Mark

Mamta Gupta, Ph.D, Guangzhen Hu, Linda E Wellik, Jing Jing Han, Mary Stenson, B.S, Ahmet Dogan, MD, PhD, Thomas E Witzig, MD

Blood (2013) 122 (21): 632.

https://doi.org/10.1182/blood.V122.21.632.632

Published: 2013

Journal Articles

Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP

Mamta Gupta, Matthew J. Maurer, Linda E. Wellik, Mark E. Law, Jing Jing Han, Nazan Ozsan, Ivana N. Micallef, Ahmet Dogan, Thomas E. Witzig

Blood (2012) 120 (22): 4400–4406.

https://doi.org/10.1182/blood-2012-05-428466

Published: 2012

Includes: Supplemental data

Journal Articles

A Novel STAT3 mutation Associated with Diffuse Large B Cell Lymphoma Deregulates STAT3 Signaling.

Guangzhen Hu, Thomas E. Witzig, MD, Mamta Gupta, Ph.D

Blood (2012) 120 (21): 2690.

https://doi.org/10.1182/blood.V120.21.2690.2690

Published: 2012

Journal Articles

Expression of MYC but Not pSTAT3 Is an Adverse Prognostic Factor for Diffuse Large B Cell Lymphoma (DLBCL) Treated with Epratuzumab/R-CHOP

Mamta Gupta, Ph.D, Matthew J Maurer, MS, Linda Wellik, Mark E Law, Jing Jing Han, Ivana N. Micallef, MD, Ahmet Dogan, MD, PhD, Thomas E. Witzig, MD

Blood (2012) 120 (21): 1575.

https://doi.org/10.1182/blood.V120.21.1575.1575

Published: 2012

Journal Articles

Expression but Not Promoter Hypermethylation of the Tyrosine Phosphatase PTPN6 Is Associated with Activated STAT3 and Inferior Prognosis in Diffuse Large B Cell Lymphoma Molecular Subtypes.

Mamta Gupta, Ph.D, Guangzhen Hu, Steven Offer, Matthew J Maurer, MS, Linda Wellik, Jing Jing Han, Ahmet Dogan, MD, PhD, Robert B. Diasio, MD, Thomas E. Witzig, MD

Blood (2012) 120 (21): 2655.

https://doi.org/10.1182/blood.V120.21.2655.2655

Published: 2012

Journal Articles

t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth

Stephen M. Ansell, Takashi Akasaka, Ellen McPhail, Michelle Manske, Esteban Braggio, Tammy Price-Troska, Steven Ziesmer, Frank Secreto, Rafael Fonseca, Mamta Gupta, Mark Law, Thomas E. Witzig, Martin J. S. Dyer, Ahmet Dogan, James R. Cerhan, Anne J. Novak

Blood (2012) 120 (19): 3949–3957.

https://doi.org/10.1182/blood-2011-11-389908

Published: 2012

Includes: Supplemental data

NARROW

Transcriptome Analysis at Locus-Specific Resolution Identified Alteration in Human Endogenous Retroviruses, a Class of Transposable Elements in Mantle Cell Lymphoma

Macrophages in Waldenstrom Macroglobulinemia: Implications for the Tumor Microenvironment

Transcriptomic Analysis in Mantle Cell Lymphoma Patients Identified MALAT1 Long-Non-Coding RNA to Regulate Cell Cycle Progression By Modulating EZH2/p57/Sox11 Axis

Tumor Microenvironment-Induced Interleukin-6 Regulates Proliferation and Survival in Patients with Mantle Cell Lymphoma (MCL) By Activating FGFR1 Signaling

Oncogenic Role of Chromatin Modifier Polycomb Repressive Complex-2 in Mantle Cell Lymphoma

Targeting Bromodomain and External Domain Epigenetic Reader Protein As Effective Strategy for Double-Hit and Triple-Hit B-Cell Lymphoma

Selective Inhibition of HDAC1 and HDAC3 Inhibits Survival of Diffuse Large Cell Lymphoma Via Epigenetic Modulation of Death Associated Protein (DAPK)

The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma

Loss-of-Function Missense Mutations in Tyrosine Phosphatase PTPN6 Deregulate STAT3 Signaling in Diffuse Large B-Cell Lymphoma

Mantle Cell Lymphoma Associated Long Non-Coding RNAs Regulate Polycomb Repressive Complex-2

Elevated Soluble IL-2Ra Levels Are Associated With Inferior Outcome and Is Independent Of MIPI Score in Patients With Mantle Cell Lymphoma

Repression Of Cap-Dependent Translation With a Next-Generation mTOR Inhibitor Attenuates c-Myc Transcription and Survival In Lymphoma Cells

In-Vivo Activation Of STAT3 In Angioimmunoblastic T Cell Lymphoma, PTCL Not Otherwise Specified, and ALK Negative Anaplastic Large Cell Lymphoma: Implications For Therapy

A Novel Long Non-Coding RNA, SNHG4 Complex With Eukaryotic Initiation Factor-4E and Regulate Aberrant Protein Translation In Mantle Cell Lymphoma: Implications For Novel Biomarker

SHP1 Suppression In Diffuse Large B Cell Lymphoma Is Regulated Through Promoter Hypermethylation At Novel CpG2 Island and H3K27 Trimethylation Histone Mark

Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP

A Novel STAT3 mutation Associated with Diffuse Large B Cell Lymphoma Deregulates STAT3 Signaling.

Expression of MYC but Not pSTAT3 Is an Adverse Prognostic Factor for Diffuse Large B Cell Lymphoma (DLBCL) Treated with Epratuzumab/R-CHOP

Expression but Not Promoter Hypermethylation of the Tyrosine Phosphatase PTPN6 Is Associated with Activated STAT3 and Inferior Prognosis in Diffuse Large B Cell Lymphoma Molecular Subtypes.

t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only